Back to IKT
Nuveen, LLC IKT Position History
Inhibikase Therapeutics, Inc. • Healthcare
Quarters held
11
Latest value
$374K
Q3 2026
Peak value
$499K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $127K |
| Q4 2025 | $161K |
| Q1 2026 | $81K |
| Q1 2026 | $499K |
| Q1 2026 | $214K |
| Q2 2026 | $97K |
| Q2 2026 | $438K |
| Q2 2026 | $328K |
| Q3 2026 | $108K |
| Q3 2026 | $375K |
| Q3 2026 | $374K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $374K | 182.1K | — | — |
| Q3 2026 | $375K | 182.4K | — | — |
| Q3 2026 | $108K | 52.5K | — | — |
| Q2 2026 | $328K | 161.8K | — | — |
| Q2 2026 | $438K | 215.8K | — | — |
| Q2 2026 | $97K | 48.0K | — | — |
| Q1 2026 | $214K | 127.6K | — | — |
| Q1 2026 | $499K | 296.8K | — | — |
| Q1 2026 | $81K | 48.0K | — | — |
| Q4 2025 | $161K | 78.7K | — | — |
| Q3 2025 | $127K | 78.7K | — | — |